• 繁

    • -+ 0.00%
    -+ 0.00%
    -+ 0.00%

    SUSS MicroTec (XTRA:SMHN) Reports Weaker Earnings, Is It Still 20% Below Fair Value?

    Simply Wall St·08/09/2026 20:23:43
    語音播報

    SUSS MicroTec (XTRA:SMHN) has drawn investor attention after its latest earnings release showed lower sales and net income for the second quarter and first half of 2026 compared with the prior year.

    See our latest analysis for SUSS MicroTec.

    Despite the weaker second quarter, SUSS MicroTec’s share price has moved sharply over the past year, with a 1-year total shareholder return of 169.71% and a year to date share price return of 103.72%. Shorter term share price momentum has faded slightly, with a 30 day share price return of a 1.89% decline and a 90 day share price return of a 4.53% decline from the current €83.2 level.

    If this kind of move has your attention, it can help to see what else is on the move in semiconductors and adjacent fields through the 56 AI infrastructure stocks.

    SUSS MicroTec now sits at €83.2 after a steep 1 year run and a weaker first half on the earnings front. Does the current valuation still stack up for buyers, or has the balance of risk and reward shifted?

    Most Popular Narrative: 20% Undervalued

    At €83.2, SUSS MicroTec trades below a narrative fair value of €103.94, so the key question is what has to go right for that gap to close.

    Upcoming launches of next-generation tools (e.g., MaskTrack Smart for mid-end markets and new UV projection scanners) are expected to expand SUSS MicroTec's addressable market, particularly as demand for AI chips, IoT devices, and advanced packaging solutions accelerates worldwide. This can drive revenue growth and support premium pricing, especially as customers express preorder interest before official product release.

    Read the complete narrative.

    Want to see the blueprint behind that valuation gap? The narrative leans on faster revenue growth, higher margins, and a richer earnings multiple than today.

    Result: Fair Value of €103.94 (UNDERVALUED)

    Have a read of the narrative in full and understand what's behind the forecasts.

    However, SUSS MicroTec also faces pressure from weaker China demand and a lower book to bill ratio, which could weigh on future orders and earnings.

    Find out about the key risks to this SUSS MicroTec narrative.

    Another View on SUSS MicroTec’s Valuation

    The narrative fair value for SUSS MicroTec points to a 20% undervaluation at €83.2. Yet on simple earnings multiples the picture is less forgiving. The stock trades on a P/E of 61.2x, above a fair ratio of 56.5x and above peer averages of 34.6x and 55.2x. Is the premium signalling quality or stretched expectations?

    For a closer look at what these P/E gaps could mean for upside and downside risk, it is worth reviewing a more granular valuation breakdown. This includes how the fair ratio might act as an anchor over time, through the See what the numbers say about this price — find out in our valuation breakdown..

    XTRA:SMHN P/E Ratio as at Aug 2026
    XTRA:SMHN P/E Ratio as at Aug 2026

    Next Steps

    There are mixed signals on SUSS MicroTec so far. If you want to move quickly and build your own view, start with the 3 key rewards and 2 important warning signs.

    Looking for more investment ideas beyond SUSS MicroTec?

    If you want to keep your edge after assessing SUSS MicroTec, do not stop here. Fresh ideas can help you compare quality, value, and risk.

    This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.